Correlates of Immunity to Filovirus Infection

Por Bradfute, Steven B., Bavari, Sina
Publicado em 2011

Human Antibodies to Bacterial Superantigens and Their Ability To Inhibit T-Cell Activation and Lethality

Por LeClaire, Ross D., Bavari, Sina
Publicado em 2001

Shedding Light on Filovirus Infection with High-Content Imaging

Por Pegoraro, Gianluca, Bavari, Sina, Panchal, Rekha G.
Publicado em 2012

Filovirus vaccines

Por Bradfute, Steven B, Dye, John M, Bavari, Sina
Publicado em 2011

Applications of In Vivo Imaging in the Evaluation of the Pathophysiology of Viral and Bacterial Infections and in Development of Countermeasures to BSL3/4 Pathogens

Por Bocan, Thomas M., Panchal, Rekha G., Bavari, Sina
Publicado no Mol Imaging Biol (2014)

Protection against Bacterial Superantigen Staphylococcal Enterotoxin B by Passive Vaccination

Por LeClaire, Ross D., Hunt, Robert E., Bavari, Sina
Publicado em 2002

A STAT-1 knockout mouse model for Machupo virus pathogenesis

Por Bradfute, Steven B, Stuthman, Kelly S, Shurtleff, Amy C, Bavari, Sina
Publicado em 2011

High-Affinity, Protective Antibodies to the Binding Domain of Botulinum Neurotoxin Type A

Por Pless, Dorothy D., Torres, Edna R., Reinke, Emily K., Bavari, Sina
Publicado em 2001

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model

Por Kalina, Warren V, Warfield, Kelly L, Olinger, Gene G, Bavari, Sina
Publicado em 2009

Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans

Por Salerno-Gonçalves, Rosangela, Hepburn, Matthew J, Bavari, Sina, Sztein, Marcelo B.
Publicado em 2009

Key Genomic Changes Necessary for an In Vivo Lethal Mouse Marburgvirus Variant Selection Process

Por Lofts, Loreen L., Wells, Jay B., Bavari, Sina, Warfield, Kelly L.
Publicado em 2011

The International Code of Virus Classification and Nomenclature (ICVCN): proposal to delete Rule 3.41

Por Kuhn, Jens H., Radoshitzky, Sheli R., Bavari, Sina, Jahrling, Peter B.
Publicado em 2012

Humanized mice as a preclinical tool for infectious disease and biomedical research

Por Shultz, Leonard D., Brehm, Michael A., Bavari, Sina, Greiner, Dale L.
Publicado em 2011

THE INTERNATIONAL CODE OF VIRUS CLASSIFICATION AND NOMENCLATURE (ICVCN): PROPOSAL FOR TEXT CHANGES FOR IMPROVED DIFFERENTIATION OF VIRAL TAXA AND VIRUSES

Por Kuhn, Jens H., Radoshitzky, Sheli R., Bavari, Sina, Jahrling, Peter B.
Publicado em 2013

Ebola Virus Disease Candidate Vaccines Under Evaluation in Clinical Trials

Por Martins, Karen A., Jahrling, Peter B., Bavari, Sina, Kuhn, Jens H.
Publicado no Expert Rev Vaccines (2016)

Persistence of Zinc-Binding Bacterial Superantigens at the Surface of Antigen-Presenting Cells Contributes to the Extreme Potency of These Superantigens as T-Cell Activators

Por Pless, Dorothy D., Ruthel, Gordon, Reinke, Emily K., Ulrich, Robert G., Bavari, Sina
Publicado em 2005

Treatment of highly pathogenic filovirus infections using advanced antisense technology

Por Warren, Travis, Warfield, Kelly, Wells, Jay, Swenson, Dana, Lovejoy, Candace, Iversen, Patrick, Bavari, Sina
Publicado em 2010

Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails

Por Silva, Leslie P., Vanzile, Michael, Bavari, Sina, Aman, J. M. Javad, Schriemer, David C.
Publicado em 2012

Pre-symptomatic diagnosis and treatment of filovirus diseases

Por Shurtleff, Amy C., Whitehouse, Chris A., Ward, Michael D., Cazares, Lisa H., Bavari, Sina
Publicado no Front Microbiol (2015)

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge

Por Konduru, Krishnamurthy, Shurtleff, Amy C., Bradfute, Steven B., Nakamura, Siham, Bavari, Sina, Kaplan, Gerardo
Publicado no PLoS One (2016)